2.71
-0.09(-3.21%)
Currency In USD
| Previous Close | 2.8 |
| Open | 2.84 |
| Day High | 2.99 |
| Day Low | 2.68 |
| 52-Week High | 10.79 |
| 52-Week Low | 2.36 |
| Volume | 877,077 |
| Average Volume | 845,185 |
| Market Cap | 170.45M |
| PE | -3.39 |
| EPS | -0.8 |
| Moving Average 50 Days | 3.25 |
| Moving Average 200 Days | 5.72 |
| Change | -0.09 |
If you invested $1000 in Treace Medical Concepts, Inc. (TMCI) since IPO date, it would be worth $106.15 as of January 14, 2026 at a share price of $2.71. Whereas If you bought $1000 worth of Treace Medical Concepts, Inc. (TMCI) shares 3 years ago, it would be worth $103.36 as of January 14, 2026 at a share price of $2.71.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Treace Announces Preliminary, Unaudited Fourth Quarter and Full-Year 2025 Revenue
GlobeNewswire Inc.
Yesterday at 12:05 PM GMT
PONTE VEDRA, Fla., Jan. 13, 2026 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot defor
Treace Announces First Surgical Case Utilizing Lapiplasty® Lightning™ Technology
GlobeNewswire Inc.
Jan 08, 2026 9:05 PM GMT
PONTE VEDRA, Fla., Jan. 08, 2026 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot defor
Treace to Present at 44th Annual J.P. Morgan Healthcare Conference
GlobeNewswire Inc.
Dec 30, 2025 9:05 PM GMT
PONTE VEDRA, Fla., Dec. 30, 2025 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot defor